Ultragenyx Pharmaceutical Inc. - Common Stock (RARE)
CUSIP: 90400D108
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 98,367,418
- Total 13F shares
- 88,212,580
- Share change
- +8,351,138
- Total reported value
- $3,625,598,894
- Put/Call ratio
- 43%
- Price per share
- $41.10
- Number of holders
- 273
- Value change
- +$337,028,289
- Number of buys
- 161
- Number of sells
- 119
Quarterly Holders Quick Answers
What is CUSIP 90400D108?
CUSIP 90400D108 identifies RARE - Ultragenyx Pharmaceutical Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 90400D108:
Top shareholders of RARE - Ultragenyx Pharmaceutical Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
8.8%
|
8,700,007
|
$406,203,327 | — | 31 Mar 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
7.2%
|
7,087,115
|
$330,897,399 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.3%
|
5,235,738
|
$244,456,608 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
4.2%
|
4,097,975
|
$191,334,453 | — | 31 Mar 2024 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.9%
|
3,859,447
|
$180,197,580 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.6%
|
3,568,873
|
$166,632,000 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.9%
|
2,851,250
|
$133,124,863 | — | 31 Mar 2024 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.4%
|
2,400,854
|
$112,095,877 | — | 31 Mar 2024 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.3%
|
2,241,832
|
$104,671,136 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2%
|
1,938,680
|
$90,516,969 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.8%
|
1,774,938
|
$82,871,855 | — | 31 Mar 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
1,676,811
|
$78,290,306 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.5%
|
1,482,471
|
$69,216,571 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.5%
|
1,466,547
|
$68,473,079 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
1,339,826
|
$62,568,841 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.2%
|
1,207,225
|
$56,365,335 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.1%
|
1,036,374
|
$48,455,090 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.99%
|
968,990
|
$45,242,142 | — | 31 Mar 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.95%
|
933,500
|
$43,585,115 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.93%
|
911,656
|
$42,565,244 | — | 31 Mar 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.84%
|
830,000
|
$38,752,700 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.81%
|
798,504
|
$37,282,152 | — | 31 Mar 2024 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.8%
|
790,446
|
$36,905,924 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.8%
|
782,032
|
$36,513,074 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.72%
|
707,905
|
$33,052,084 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.7%
|
687,619
|
$32,104,931 | — | 31 Mar 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.59%
|
581,551
|
$27,152,617 | — | 31 Mar 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.53%
|
517,597
|
$24,166,604 | — | 31 Mar 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.52%
|
507,095
|
$23,677,000 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.51%
|
504,382
|
$23,549,594 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.51%
|
502,852
|
$23,478,160 | — | 31 Mar 2024 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.5%
|
488,138
|
$22,791,163 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.49%
|
484,381
|
$22,615,749 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.46%
|
448,200
|
$20,926,458 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.45%
|
440,798
|
$20,580,855 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.44%
|
430,536
|
$20,101,727 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.42%
|
415,314
|
$19,391,011 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.41%
|
400,124
|
$18,681,790 | — | 31 Mar 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.4%
|
389,291
|
$18,175,997 | — | 31 Mar 2024 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.39%
|
385,340
|
$17,991,525 | — | 31 Mar 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.37%
|
368,219
|
$17,192,194 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.37%
|
367,623
|
$17,164,318 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.37%
|
364,122
|
$17,000,855 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.37%
|
363,367
|
$16,965,605 | — | 31 Mar 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.36%
|
359,000
|
$16,761,710 | — | 31 Mar 2024 | |
| AXA S.A. |
13F
|
Company |
0.34%
|
332,767
|
$15,536,891 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.31%
|
305,100
|
$14,245,119 | — | 31 Mar 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.31%
|
303,377
|
$14,165,000 | — | 31 Mar 2024 | |
| Eagle Health Investments LP |
13F
|
Company |
0.3%
|
299,700
|
$13,992,993 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.3%
|
293,305
|
$13,694,410 | — | 31 Mar 2024 |
Institutional Holders of Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) as of Q2 2024
As of 30 Jun 2024,
Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) was held by
273 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
88,212,580 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., SANDS CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Clearbridge Investments, LLC, ALKEON CAPITAL MANAGEMENT LLC, and FEDERATED HERMES, INC..
This page lists
273
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
268
Q2 2024 holders
273
Holder diff
5
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.